Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Image | 5 | 2016 | 39 | 1.790 |
Why?
|
| Overweight | 4 | 2016 | 377 | 1.140 |
Why?
|
| Health Status | 2 | 2025 | 387 | 1.020 |
Why?
|
| Body Weight | 6 | 2016 | 986 | 1.000 |
Why?
|
| Anti-HIV Agents | 2 | 2025 | 359 | 0.820 |
Why?
|
| HIV Infections | 7 | 2025 | 2025 | 0.760 |
Why?
|
| Sleep | 4 | 2025 | 374 | 0.740 |
Why?
|
| Congenital Abnormalities | 4 | 2017 | 318 | 0.730 |
Why?
|
| Depression | 4 | 2015 | 1325 | 0.730 |
Why?
|
| Sleep Deprivation | 2 | 2014 | 44 | 0.700 |
Why?
|
| Liver Cirrhosis | 6 | 2025 | 899 | 0.690 |
Why?
|
| Obesity | 7 | 2024 | 2377 | 0.680 |
Why?
|
| Adolescent Behavior | 2 | 2016 | 170 | 0.670 |
Why?
|
| Vietnam | 12 | 2026 | 66 | 0.650 |
Why?
|
| Prospective Studies | 17 | 2026 | 6443 | 0.630 |
Why?
|
| Pediatric Obesity | 2 | 2015 | 416 | 0.630 |
Why?
|
| Anxiety Disorders | 2 | 2016 | 710 | 0.630 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2012 | 101 | 0.590 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2025 | 400 | 0.580 |
Why?
|
| Self Concept | 2 | 2015 | 162 | 0.520 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2025 | 996 | 0.470 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 102 | 0.470 |
Why?
|
| Parity | 2 | 2015 | 84 | 0.470 |
Why?
|
| Quality of Life | 1 | 2025 | 2096 | 0.450 |
Why?
|
| Risk | 5 | 2015 | 738 | 0.450 |
Why?
|
| Liver Neoplasms | 4 | 2025 | 1383 | 0.420 |
Why?
|
| Adolescent | 18 | 2020 | 20812 | 0.410 |
Why?
|
| Mood Disorders | 2 | 2013 | 128 | 0.400 |
Why?
|
| Body Mass Index | 7 | 2024 | 1680 | 0.400 |
Why?
|
| Weight Perception | 1 | 2013 | 1 | 0.400 |
Why?
|
| Social Perception | 1 | 2013 | 54 | 0.400 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 197 | 0.380 |
Why?
|
| Viral Load | 3 | 2019 | 405 | 0.360 |
Why?
|
| Female | 30 | 2025 | 70740 | 0.350 |
Why?
|
| Male | 29 | 2025 | 64819 | 0.350 |
Why?
|
| Baths | 1 | 2011 | 15 | 0.350 |
Why?
|
| Odds Ratio | 5 | 2014 | 1233 | 0.350 |
Why?
|
| Sex Factors | 4 | 2016 | 1343 | 0.340 |
Why?
|
| Hot Temperature | 1 | 2011 | 144 | 0.330 |
Why?
|
| Hand Hygiene | 2 | 2020 | 18 | 0.320 |
Why?
|
| Maternal Exposure | 1 | 2011 | 150 | 0.310 |
Why?
|
| Primary Health Care | 3 | 2025 | 785 | 0.310 |
Why?
|
| Humans | 38 | 2026 | 130912 | 0.290 |
Why?
|
| Surveys and Questionnaires | 6 | 2025 | 4007 | 0.290 |
Why?
|
| Logistic Models | 3 | 2025 | 1822 | 0.280 |
Why?
|
| Child | 13 | 2020 | 26096 | 0.270 |
Why?
|
| Cohort Studies | 6 | 2016 | 5095 | 0.270 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 409 | 0.250 |
Why?
|
| Hepatitis C | 2 | 2023 | 389 | 0.240 |
Why?
|
| Socioeconomic Factors | 2 | 2025 | 896 | 0.230 |
Why?
|
| Hypnotics and Sedatives | 1 | 2026 | 133 | 0.220 |
Why?
|
| Critical Pathways | 1 | 2025 | 74 | 0.220 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2024 | 19 | 0.210 |
Why?
|
| Interferons | 1 | 2025 | 136 | 0.210 |
Why?
|
| Adult | 13 | 2025 | 31533 | 0.210 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1511 | 0.200 |
Why?
|
| Risk Factors | 11 | 2025 | 10900 | 0.190 |
Why?
|
| Respiration, Artificial | 1 | 2026 | 503 | 0.190 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2023 | 60 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2026 | 410 | 0.190 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 257 | 0.180 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 228 | 0.180 |
Why?
|
| Infection Control | 2 | 2020 | 161 | 0.180 |
Why?
|
| Critical Illness | 1 | 2026 | 612 | 0.180 |
Why?
|
| Texas | 4 | 2016 | 3604 | 0.180 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 344 | 0.180 |
Why?
|
| Colitis, Ulcerative | 1 | 2023 | 216 | 0.170 |
Why?
|
| Health Personnel | 3 | 2020 | 548 | 0.170 |
Why?
|
| Hodgkin Disease | 1 | 2023 | 311 | 0.160 |
Why?
|
| Critical Care | 1 | 2026 | 678 | 0.160 |
Why?
|
| Hepatitis C, Chronic | 1 | 2025 | 367 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2023 | 291 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2020 | 392 | 0.160 |
Why?
|
| Middle Aged | 10 | 2025 | 28730 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 391 | 0.160 |
Why?
|
| Exercise | 1 | 2025 | 865 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 323 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2025 | 811 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 1395 | 0.140 |
Why?
|
| Heroin | 1 | 2018 | 19 | 0.140 |
Why?
|
| Heroin Dependence | 1 | 2018 | 57 | 0.140 |
Why?
|
| Common Cold | 1 | 2017 | 24 | 0.140 |
Why?
|
| HIV | 1 | 2019 | 178 | 0.140 |
Why?
|
| Opiate Substitution Treatment | 1 | 2018 | 38 | 0.140 |
Why?
|
| United States | 7 | 2025 | 11716 | 0.130 |
Why?
|
| Methadone | 1 | 2018 | 126 | 0.130 |
Why?
|
| Patient Participation | 1 | 2020 | 244 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2024 | 804 | 0.130 |
Why?
|
| HIV-1 | 2 | 2018 | 476 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3799 | 0.130 |
Why?
|
| Cross Infection | 1 | 2020 | 338 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5256 | 0.120 |
Why?
|
| Income | 1 | 2016 | 135 | 0.120 |
Why?
|
| Psychology, Adolescent | 1 | 2015 | 35 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 376 | 0.120 |
Why?
|
| Time Factors | 2 | 2016 | 6275 | 0.120 |
Why?
|
| Birth Order | 1 | 2015 | 8 | 0.110 |
Why?
|
| Fever | 1 | 2017 | 311 | 0.110 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2015 | 42 | 0.110 |
Why?
|
| Aged | 8 | 2025 | 21134 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2023 | 3432 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2024 | 3675 | 0.100 |
Why?
|
| Telemedicine | 1 | 2020 | 504 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2015 | 172 | 0.100 |
Why?
|
| Pregnancy | 4 | 2017 | 7551 | 0.100 |
Why?
|
| Liver Abscess, Amebic | 1 | 2002 | 4 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 500 | 0.090 |
Why?
|
| Amebiasis | 1 | 2002 | 11 | 0.090 |
Why?
|
| Smoking | 1 | 2017 | 925 | 0.090 |
Why?
|
| Hernia, Umbilical | 1 | 2012 | 43 | 0.090 |
Why?
|
| Prevalence | 3 | 2022 | 2679 | 0.090 |
Why?
|
| Comorbidity | 1 | 2016 | 1587 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2017 | 702 | 0.090 |
Why?
|
| Young Adult | 5 | 2018 | 10037 | 0.080 |
Why?
|
| Attitude to Health | 1 | 2011 | 251 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 842 | 0.080 |
Why?
|
| Intensive Care Units | 2 | 2026 | 511 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 2287 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 390 | 0.070 |
Why?
|
| Registries | 1 | 2015 | 1591 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2019 | 228 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 548 | 0.060 |
Why?
|
| Age Distribution | 1 | 2007 | 428 | 0.060 |
Why?
|
| Age Factors | 1 | 2013 | 2866 | 0.060 |
Why?
|
| Disease Progression | 2 | 2024 | 2191 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2024 | 61 | 0.050 |
Why?
|
| Lipase | 1 | 2024 | 88 | 0.050 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2023 | 39 | 0.050 |
Why?
|
| Achievement | 1 | 2013 | 32 | 0.050 |
Why?
|
| Self-Injurious Behavior | 1 | 2013 | 67 | 0.050 |
Why?
|
| Phenotype | 1 | 2012 | 4492 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2013 | 322 | 0.050 |
Why?
|
| Health Facilities | 1 | 2022 | 68 | 0.040 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 152 | 0.040 |
Why?
|
| Social Stigma | 1 | 2022 | 82 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2025 | 564 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 221 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1401 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2018 | 17483 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 434 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1248 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1892 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2026 | 699 | 0.040 |
Why?
|
| Health Resources | 1 | 2020 | 128 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 439 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 153 | 0.030 |
Why?
|
| Family | 1 | 2020 | 588 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1611 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 679 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 350 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 260 | 0.030 |
Why?
|
| Live Birth | 1 | 2015 | 69 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 787 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 896 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3396 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2122 | 0.020 |
Why?
|
| Entamoeba | 1 | 2002 | 3 | 0.020 |
Why?
|
| Population | 1 | 2002 | 22 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2015 | 397 | 0.020 |
Why?
|
| Geography | 1 | 2002 | 119 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2002 | 99 | 0.020 |
Why?
|
| Urban Population | 1 | 2002 | 281 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3067 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8541 | 0.020 |
Why?
|
| Incidence | 1 | 2002 | 3326 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 13210 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 14944 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 34275 | 0.010 |
Why?
|